Yuelei Shen is the founder of Biocytogen. Latest round: Growth. Backed by SDIC Venture Capital, 3E Bioventures, Cowin Capital Group. Based in Beijing, China.
Dr. Yuelei Shen is the founder, Chairman, President, and CEO of Biocytogen, a global biotechnology company established in 2009. He leads the company's development of novel antibody-based drugs and gene-edited animal models, including RenMab and BioMice, overseeing both therapeutic antibodies and animal models business segments.
Full founder directory · Investor directory · Company funding database · Fundraising library